{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:50:24Z","timestamp":1794963024547,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with mechanical heart valves require lifelong oral anticoagulation with vitamin K antagonists such as warfarin to prevent valve-associated thromboembolism. Bleeding complications during this therapy pose significant clinical challenges and necessitate expert management. In particular, heavy uterine bleeding following miscarriage represents a high-risk and emergent situation. The management of uterine bleeding is challenging, due to the need to balance anticoagulation with hemostatic control. This report presents a case of severe and prolonged bleeding caused by retained product of conception in a patient with mechanical heart valves receiving vitamin K antagonist therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We describe the case of a 28-year-old African woman with mechanical double heart valve prosthesis maintained on warfarin therapy who initially underwent vacuum curettage for a missed abortion. Two weeks later, she presented with heavy vaginal bleeding. Despite initial expectant management, recurrent bleeding episodes necessitated multiple interventions including repeat curettage, off-label intrauterine tamponade, blood transfusions, and bridging with unfractionated heparin. Persistent hemorrhage led to attempted endometrial ablation, followed by successful uterine artery embolization, which effectively controlled hemorrhage and preserved the uterus. The patient was closely monitored from both a cardiologic and hemostatic perspective, and anticoagulation therapy was resumed with stable prosthetic valve function observed at discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The management of miscarriage-associated bleeding in patients receiving warfarin anticoagulation for mechanical heart valves is complex and necessitates interdisciplinary collaboration. A stepwise multimodal approach incorporating gynecological, hematological, radiological, and cardiological expertise can achieve hemorrhage control while maintaining an appropriate balance between thrombotic and bleeding risks. Organ-preserving interventions such as uterine artery embolization may offer viable alternatives to hysterectomy in selected cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-026-05991-3","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:19:00Z","timestamp":1775128740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Critical uterine bleeding after miscarriage in a warfarin-anticoagulated patient with mechanical heart valve: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Melanie","family":"Poloczek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8918-6360","authenticated-orcid":false,"given":"Barbara","family":"Kipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"5991_CR1","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","volume":"397","author":"S Quenby","year":"2021","unstructured":"Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, Fisher J, et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021;397:1658\u201367.","journal-title":"Lancet"},{"key":"5991_CR2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/AOG.0b013e3181b79796","volume":"114","author":"R Hasan","year":"2009","unstructured":"Hasan R, Baird DD, Herring AH, Olshan AF, Jonsson Funk ML, Hartmann KE. Association between first-trimester vaginal bleeding and miscarriage. Obstet Gynecol. 2009;114:860\u20137.","journal-title":"Obstet Gynecol"},{"key":"5991_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/humrep\/dew010","volume":"31","author":"KJ Sapra","year":"2016","unstructured":"Sapra KJ, Buck Louis GM, Sundaram R, Joseph KS, Bates LM, Galea S, et al. Signs and symptoms associated with early pregnancy loss: findings from a population-based preconception cohort. Hum Reprod. 2016;31:887\u201396.","journal-title":"Hum Reprod"},{"key":"5991_CR4","first-page":"240","volume":"27","author":"ZA Ashour","year":"2000","unstructured":"Ashour ZA, Shawky HAF, Hussein MH. Outcome of pregnancy in women with mechanical valves. Tex Heart Inst J. 2000;27:240.","journal-title":"Tex Heart Inst J"},{"key":"5991_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.115.015242","volume":"132","author":"IM Van Hagen","year":"2015","unstructured":"Van Hagen IM, Roos-Hesselink JW, Ruys TPE, Merz WM, Goland S, Gabriel H, et al. Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 2015;132:132\u201342.","journal-title":"Circulation"},{"key":"5991_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1515\/crpm-2015-0102","volume":"5","author":"JL Perdigao","year":"2016","unstructured":"Perdigao JL, McQueen D, Nunes K, DiGiovanni L. Postpartum hemorrhage in the setting of a mechanical heart valve. Case Rep Perinat Med. 2016;5:93\u20136.","journal-title":"Case Rep Perinat Med"},{"key":"5991_CR7","first-page":"908","volume":"109","author":"PK Saha","year":"2011","unstructured":"Saha PK, Rakshit BM, Jana N, Dutta S, Roy SB, Sengupta G. Management of abnormal uterine bleeding in women with mechanical heart valve prosthesis and anticoagulant therapy. J Indian Med Assoc. 2011;109:908\u201311.","journal-title":"J Indian Med Assoc"},{"key":"5991_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028653","volume":"12","author":"AP Ng","year":"2023","unstructured":"Ng AP, Verma A, Sanaiha Y, Williamson CG, Afshar Y, Benharash P. Maternal and fetal outcomes in pregnant patients with mechanical and bioprosthetic heart valves. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2023;12: e028653.","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"key":"5991_CR9","first-page":"267","volume":"108","author":"V Regitz-Zagrosek","year":"2011","unstructured":"Regitz-Zagrosek V, Seeland U, Geibel-Zehender A, Gohlke-B\u00e4rwolf C, Kruck I, Schaefer C. Herz-Kreislauf-Erkrankungen in der Schwangerschaft. Dtsch Arztebl. 2011;108:267\u201373.","journal-title":"Dtsch Arztebl"},{"key":"5991_CR10","doi-asserted-by":"crossref","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, rwin JP, Gentile F, et al. 2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:E72\u2013227.","DOI":"10.1161\/CIR.0000000000000923"},{"key":"5991_CR11","volume":"13","author":"SA Huda","year":"2021","unstructured":"Huda SA, Kahlown S, Jilani MH, Chaudhuri D. Management of life-threatening bleeding in patients with mechanical heart valves. Cureus. 2021;13: e15619.","journal-title":"Cureus"},{"key":"5991_CR12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/eurheartj\/ehx032","volume":"38","author":"R D\u2019Souza","year":"2017","unstructured":"D\u2019Souza R, Ostro J, Shah PS, Silversides CK, Malinowski A, Murphy KE, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017;38:1509\u201316.","journal-title":"Eur Heart J"},{"key":"5991_CR13","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1016\/j.jacc.2017.03.605","volume":"69","author":"ZL Steinberg","year":"2017","unstructured":"Steinberg ZL, Dominguez-Islas CP, Otto CM, Stout KK, Krieger EV. Maternal and fetal outcomes of anticoagulation in pregnant women with mechanical heart valves. J Am Coll Cardiol. 2017;69:2681\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"5991_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/icvts\/ivu009","volume":"18","author":"A Hassouna","year":"2014","unstructured":"Hassouna A, Allam H. Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2014;18:797\u2013806.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"5991_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s40264-021-01072-0","volume":"44","author":"E Eworuke","year":"2021","unstructured":"Eworuke E, Hou L, Zhang R, Wong HL, Waldron P, Anderson A, et al. Risk of severe abnormal uterine bleeding associated with rivaroxaban compared with apixaban. Dabigatran Warfarin Drug Saf. 2021;44:753\u201363.","journal-title":"Dabigatran Warfarin Drug Saf"},{"key":"5991_CR16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692\u20134.","journal-title":"J Thromb Haemost"},{"key":"5991_CR17","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","volume":"389","author":"H Shakur","year":"2017","unstructured":"Shakur H, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, Akintan A, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. The Lancet. 2017;389:2105\u201316.","journal-title":"The Lancet"},{"key":"5991_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jacc.2020.04.053","volume":"76","author":"GF Tomaselli","year":"2020","unstructured":"Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, et al. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020;76:594\u2013622.","journal-title":"J Am Coll Cardiol"},{"key":"5991_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2025.102914","volume":"0","author":"H Pymar","year":"2025","unstructured":"Pymar H, Waddington A, Prager S, Shorter J, Thomas J. Guideline No. 460: Diagnosis and management of intrauterine early pregnancy loss. J Obstet Gynaecol Can. 2025;0: 102914.","journal-title":"J Obstet Gynaecol Can"},{"key":"5991_CR20","doi-asserted-by":"publisher","first-page":"2354382","DOI":"10.1080\/14767058.2024.2354382","volume":"37","author":"AM Dueckelmann","year":"2024","unstructured":"Dueckelmann AM, Hermann P, Biele C, Leichtle C, Waldner C, Braun T, et al. Short and long-term menstrual, reproductive, and mental health outcomes after the intrauterine use of chitosan tamponade or the Bakri balloon for severe postpartum hemorrhage: an observational study. J Matern Fetal Neonatal Med. 2024;37:2354382.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"5991_CR21","doi-asserted-by":"crossref","unstructured":"K\u00f6ksal \u00d6, \u00d6zdemi\u0307r F, \u00c7am Et\u00f6z B, I\u0307\u015fbi\u0307l B\u00fcy\u00fckco\u015fkun N, Si\u011firli D, \u00dcniversitesi T\u0131p Fak\u00fcltesi U, et al. Hemostatic effect of a chitosan linear polymer (Celox\u00ae) in a severe femoral artery bleeding rat model under hypothermia or warfarin therapy Hipotermi ve varfarin uygulanan \u015fiddetli femoral arter kanamal\u0131 s\u0131\u00e7an modelinde kitosan lineer polimer\u2019in (Celox\u00ae) hemostatik etkinli\u011fi. Turkish J Trauma Emerg Surg Exp Study Deneysel \u00c7al\u0131\u015fma Ulus Travma Acil Cerrahi Derg. 2011;17:199\u2013204.","DOI":"10.5505\/tjtes.2011.88155"},{"key":"5991_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1074-3804(98)80037-6","volume":"5","author":"MP Milad","year":"1998","unstructured":"Milad MP, Valle RF. Emergency endometrial ablation for life-threatening uterine bleeding as a result of a coagulopathy. J Am Assoc Gynecol Laparosc. 1998;5:301\u20133.","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"5991_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ijgo.12292","volume":"139","author":"S Al-Inizi","year":"2017","unstructured":"Al-Inizi S. NovaSure radiofrequency endometrial ablation for the management of acute abnormal uterine bleeding. Int J Gynaecol Obstet. 2017;139:247\u20138.","journal-title":"Int J Gynaecol Obstet"},{"issue":"5 Suppl.","key":"5991_CR24","first-page":"1092","volume":"100","author":"CM Nichols","year":"2002","unstructured":"Nichols CM, Gill EJ. Thermal balloon endometrial ablation for management of acute uterine hemorrhage. Obstet Gynecol. 2002;100(5 Suppl.):1092\u20134.","journal-title":"Obstet Gynecol"},{"key":"5991_CR25","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00261-023-03928-8","volume":"48","author":"SR Brown","year":"2023","unstructured":"Brown SR, Roane B, Caridi TM, Straughn JM, Gunn AJ. Short-term outcomes of uterine artery embolization for urgent or emergent abnormal uterine bleeding. Abdom Radiol. 2023;48:2443\u20138.","journal-title":"Abdom Radiol"},{"key":"5991_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jmig.2021.07.010","volume":"29","author":"K Wattamwar","year":"2022","unstructured":"Wattamwar K, Arabkhazaeli M, Shin JH, Korff R, Cynamon J, Golowa Y. Efficacy of uterine artery embolization for treatment of anticoagulant-associated abnormal uterine bleeding. J Minim Invasive Gynecol. 2022;29:128-134.e1.","journal-title":"J Minim Invasive Gynecol"},{"key":"5991_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.12688\/f1000research.142066.1","volume":"13","author":"S Jha","year":"2024","unstructured":"Jha S, Inamdar S, Dhobale A. Case report: uterine artery embolization after dysfunctional uterine bleeding due to incomplete abortion in female. F1000 Research. 2024;13:473.","journal-title":"F1000 Research"},{"key":"5991_CR28","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000138","volume":"2020","author":"BS Bannow","year":"2020","unstructured":"Bannow BS. Management of heavy menstrual bleeding on anticoagulation. Hematology Am Soc Hematol Educ Program. 2020;2020: 533.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"5991_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/GRF.0000000000000372","volume":"61","author":"A Rivara","year":"2018","unstructured":"Rivara A, James AH. Managing heavy menstrual bleeding in women at risk of thrombosis. Clin Obstet Gynecol. 2018;61:250\u20139.","journal-title":"Clin Obstet Gynecol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-05991-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-05991-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-05991-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:40:05Z","timestamp":1775133605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-05991-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5991"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-05991-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this single case report, in accordance with the institutional policy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}